BRPI0015610C1 - composto derivado de 3,3-difenilpropilamina, processo para preparação do mesmo, utilização de intermediários na obtenção do referido composto - Google Patents

composto derivado de 3,3-difenilpropilamina, processo para preparação do mesmo, utilização de intermediários na obtenção do referido composto

Info

Publication number
BRPI0015610C1
BRPI0015610C1 BRPI0015610A BR0015610A BRPI0015610C1 BR PI0015610 C1 BRPI0015610 C1 BR PI0015610C1 BR PI0015610 A BRPI0015610 A BR PI0015610A BR 0015610 A BR0015610 A BR 0015610A BR PI0015610 C1 BRPI0015610 C1 BR PI0015610C1
Authority
BR
Brazil
Prior art keywords
stable
salts
diphenylpropylamine
diisopropylamino
compound
Prior art date
Application number
BRPI0015610A
Other languages
English (en)
Portuguese (pt)
Other versions
BRPI0015610B1 (pt
BR0015610B8 (pt
BR0015610A (pt
Inventor
Meese Claus
Original Assignee
Sanol Arznei Schwarz Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7929277&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0015610(C1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanol Arznei Schwarz Gmbh filed Critical Sanol Arznei Schwarz Gmbh
Publication of BR0015610A publication Critical patent/BR0015610A/pt
Publication of BRPI0015610B1 publication Critical patent/BRPI0015610B1/pt
Publication of BR0015610B8 publication Critical patent/BR0015610B8/pt
Publication of BRPI0015610C1 publication Critical patent/BRPI0015610C1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
    • C07C215/54—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/06—Anti-spasmodics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C219/28—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)
  • Luminescent Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Detergent Compositions (AREA)
BRPI0015610A 1999-11-16 2000-11-15 composto derivado de 3,3-difenilpropilamina, processo para preparação do mesmo, utilização de intermediários na obtenção do referido composto BRPI0015610C1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19955190A DE19955190A1 (de) 1999-11-16 1999-11-16 Stabile Salze neuartiger Derivate von 3,3-Diphenylpropylaminen
PCT/EP2000/011309 WO2001035957A1 (de) 1999-11-16 2000-11-15 Stabile salze neuartiger derivate von 3,3-diphenylpropylaminen

Publications (4)

Publication Number Publication Date
BR0015610A BR0015610A (pt) 2002-07-30
BRPI0015610B1 BRPI0015610B1 (pt) 2016-04-19
BR0015610B8 BR0015610B8 (pt) 2017-10-31
BRPI0015610C1 true BRPI0015610C1 (pt) 2021-05-25

Family

ID=7929277

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0015610A BRPI0015610C1 (pt) 1999-11-16 2000-11-15 composto derivado de 3,3-difenilpropilamina, processo para preparação do mesmo, utilização de intermediários na obtenção do referido composto

Country Status (30)

Country Link
US (1) US6858650B1 (OSRAM)
EP (3) EP1690536B1 (OSRAM)
JP (6) JP4083431B2 (OSRAM)
KR (2) KR100536095B1 (OSRAM)
CN (1) CN1215045C (OSRAM)
AT (3) ATE395056T1 (OSRAM)
AU (1) AU778132B2 (OSRAM)
BR (1) BRPI0015610C1 (OSRAM)
CA (1) CA2389749C (OSRAM)
CY (2) CY1106204T1 (OSRAM)
CZ (2) CZ302967B6 (OSRAM)
DE (5) DE19955190A1 (OSRAM)
DK (3) DK1230209T3 (OSRAM)
EA (1) EA005588B1 (OSRAM)
ES (3) ES2303708T3 (OSRAM)
GE (1) GEP20084430B (OSRAM)
HK (1) HK1045148B (OSRAM)
HU (2) HU227608B1 (OSRAM)
IL (2) IL149567A0 (OSRAM)
IS (2) IS2124B (OSRAM)
MX (1) MXPA02004603A (OSRAM)
NO (2) NO323920B1 (OSRAM)
NZ (1) NZ519230A (OSRAM)
PL (1) PL201422B1 (OSRAM)
PT (3) PT1481964E (OSRAM)
SI (3) SI1690536T1 (OSRAM)
SK (3) SK288185B6 (OSRAM)
UA (2) UA73324C2 (OSRAM)
WO (1) WO2001035957A1 (OSRAM)
ZA (1) ZA200203315B (OSRAM)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0957073A1 (en) * 1998-05-12 1999-11-17 Schwarz Pharma Ag Novel derivatives of 3,3-diphenylpropylamines
DE19955190A1 (de) * 1999-11-16 2001-06-21 Sanol Arznei Schwarz Gmbh Stabile Salze neuartiger Derivate von 3,3-Diphenylpropylaminen
DE10028443C1 (de) * 2000-06-14 2002-05-29 Sanol Arznei Schwarz Gmbh Verfahren zur Herstellung von 3,3-Diarylpropylaminen, (R,S)- und (R)-4-Phenyl-2-chromanon-6-carbonsäure sowie (R)-4-Phenyl-2-chromanon-carbonsäure-cinchonidinsalz und deren Verwendung zur Herstellung eines rechtsdrehenden Hydroxybenzylalkohols und von pharmazeutischen Zusammensetzungen
DE10315878B4 (de) 2003-04-08 2009-06-04 Schwarz Pharma Ag Vorrichtung zur transdermalen Verabreichung von Fesoterodin und Verwendung
DE10315917A1 (de) * 2003-04-08 2004-11-18 Schwarz Pharma Ag Hochreine Basen von 3,3-Diphenylpropylaminmonoestern
WO2005012227A2 (en) * 2003-08-05 2005-02-10 Ranbaxy Laboratories Limited Process for preparation of 2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxymethyl-phenol, a metabolite of tolterodine
ES2235648B1 (es) * 2003-12-22 2006-11-01 Ragactives, S.L. Procedimiento para la obtencion de tolterodina.
US8034823B2 (en) * 2005-02-22 2011-10-11 Savvipharm Inc Method of increasing drug oral bioavailability and compositions of less toxic orotate salts
KR100647068B1 (ko) 2005-09-15 2006-11-23 하나제약 주식회사 라세믹ｎ,ｎ-디이소프로필-3-(2-히드록시-5-메틸페닐)-3-페닐프로판아민의 제조방법
DK2029567T3 (da) * 2006-05-24 2010-11-29 Pfizer Ltd Fremgangsmåde til frembringelse af benzopyran-2-ol-derivater
BRPI0711881B1 (pt) * 2006-05-31 2016-09-27 Schwarz Pharma Ltd síntese de hidroximetil fenóis substituídos
EP1862449A1 (en) * 2006-05-31 2007-12-05 Schwarz Pharma Ltd. A shortened synthesis of substituted hydroxymethyl phenols
IES20060424A2 (en) * 2006-06-08 2007-10-31 Schwarz Pharma Ltd Accelerated synthesis of (3-Diisopropylamino-1-phenylpropyl)-4-(hydroxymethyl)phenol and its phenolic monoesters
US7807715B2 (en) 2006-06-09 2010-10-05 Ucb Pharma Gmbh Pharmaceutical compositions comprising fesoterodine
CA2648333C (en) * 2006-06-09 2014-04-29 Schwarz Pharma Ltd Synthesis of phenolic esters of hydroxymethyl phenols
ATE517619T1 (de) * 2006-06-09 2011-08-15 Ucb Pharma Gmbh Stabilisierte pharmazeutische zusammensetzung mit fesoterodin
IES20060435A2 (en) * 2006-06-12 2007-12-12 Schwarz Pharma Ltd Shortened synthesis using paraformaldehyde or trioxane
AU2007260267B2 (en) 2006-06-12 2012-09-06 Ucb Pharma Gmbh New chiral intermediate, process for producing the same and its use in the manufacture of tolterodine, fesoterodine, or the active metabolite thereof
US20100217034A1 (en) * 2007-09-21 2010-08-26 Actavis Group Ptc Ehf Process for the Preparation of Fesoterodine
US20100297241A1 (en) * 2007-10-01 2010-11-25 Actavis Group Ptc Ehf Amorphous Fesoterodine Fumarate
EP2294047A2 (en) * 2008-04-04 2011-03-16 Actavis Group PTC EHF Novel mandelate salt of fesoterodine
US20110171274A1 (en) * 2008-07-21 2011-07-14 Actavis Group Ptc Ehf Fesoterodine Substantially Free of Dehydroxy Impurity
IT1392082B1 (it) * 2008-12-10 2012-02-09 Chemi Spa Nuove forme solide della fesoterodina fumarato
PL2416761T3 (pl) 2009-05-11 2015-07-31 Ratiopharm Gmbh Desfezoterodyna w postaci soli kwasu winowego
IT1394217B1 (it) 2009-05-15 2012-06-01 Chemi Spa Metodo di preparazione di fesoterodina e/o fesoterodina fumarato.
IT1394219B1 (it) * 2009-05-15 2012-06-01 Chemi Spa Metodo di preparazione di fesoterodina fumarato di elevata purezza.
KR20120053027A (ko) 2009-09-03 2012-05-24 테바 기오기스제르갸르 자르트쾨렌 뮈쾨되 레스즈베니타르사사그 페소테로딘 푸마레이트 및 페소테로딘 염기의 결정형
IT1396373B1 (it) * 2009-10-29 2012-11-19 Dipharma Francis Srl Procedimento per la preparazione di fesoterodina.
EP2316432A1 (de) 2009-10-30 2011-05-04 ratiopharm GmbH Zusammensetzung enthaltend Fesoterodin und Ballaststoffe
US20110124903A1 (en) * 2009-11-20 2011-05-26 Actavis Group Ptc Ehf Solid state forms of fesoterodine intermediates
IT1397521B1 (it) * 2009-12-21 2013-01-16 Dipharma Francis Srl Procedimento per la preparazione di fesoterodina con un basso contenuto di impurezze.
IT1397920B1 (it) * 2010-02-08 2013-02-04 Dipharma Francis Srl Forma cristallina di fesoterodina fumarato e procedimento per la sua preparazione
WO2011117884A1 (en) 2010-03-22 2011-09-29 Cadila Healthcare Limited Stable pharmaceutical compositions comprising fesoterodine
JP5812500B2 (ja) 2010-04-30 2015-11-17 メルク・シャープ・エンド・ドーム・コーポレイション 新規なβ３アドレナリン作動性受容体アゴニスト
WO2011141932A2 (en) 2010-05-11 2011-11-17 Intas Pharmaceuticals Limited Process for preparation of phenolic monoesters of hydroxymethyl phenols
WO2011145019A1 (en) * 2010-05-17 2011-11-24 Orchid Chemicals And Pharmaceuticals Limited Improved process for diphenylpropylamine derivatives
IT1401451B1 (it) 2010-06-10 2013-07-26 Chemi Spa Nuovo processo di preparazione di 2-idrossi-4-fenil-3,4-diidro-2h-cromen-6-il-metanolo e (r)-2-[3-(diisopropilammino)-1-fenilpropil]-4-(idrossimetil)fenolo.
WO2011158257A1 (en) 2010-06-18 2011-12-22 Panacea Biotec Ltd Preparation process of fesoterodine and intermediates
WO2012025941A2 (en) 2010-08-25 2012-03-01 Cadila Healthcare Limited Processes for the preparation of fesoterodine
IT1403094B1 (it) 2010-12-09 2013-10-04 Dipharma Francis Srl Procedimento per la preparazione di fesoterodina o un suo sale
WO2012098560A2 (en) * 2011-01-17 2012-07-26 Msn Laboratories Limited Process for the preparation of muscarinic receptor antagonist
TWI590821B (zh) 2011-01-18 2017-07-11 輝瑞有限公司 固體分子分散液
EP2508175A1 (en) 2011-04-08 2012-10-10 LEK Pharmaceuticals d.d. Pharmaceutical composition comprising fesoterodine or a salt or a solvate thereof
EP2508173A1 (en) 2011-04-08 2012-10-10 LEK Pharmaceuticals d.d. Stabilized pharmaceutical composition comprising fesoterodine
US9422228B2 (en) 2012-05-04 2016-08-23 Crystal Pharma, S.A.U. Process for the preparation of optically pure fesoterodine derivatives
ITMI20121232A1 (it) 2012-07-16 2014-01-17 Cambrex Profarmaco Milano Srl Procedimento per la preparazione di 2-(3-n,n-diisopropilamino-1-fenilpropil)-4-idrossimetil-fenolo e suoi derivati
TR201721437A2 (tr) 2017-12-25 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Fesoterodi̇ni̇n modi̇fi̇ye salim sağlayan formülasyonlari
CN116472262A (zh) * 2020-10-27 2023-07-21 威娜德国有限责任公司 化妆品级品质的2-甲氧基甲基-对苯二胺

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR75395B (OSRAM) * 1980-11-14 1984-07-13 Lilly Co Eli
IL66831A0 (en) * 1981-10-05 1982-12-31 Kefalas As Indane derivatives
SE8800207D0 (sv) * 1988-01-22 1988-01-22 Kabivitrum Ab Nya aminer, deras anvendning och framstellning
ATE140213T1 (de) * 1990-03-08 1996-07-15 Fujisawa Pharmaceutical Co N-monosubstituierte cyclopentenylamine, ein verfahren zu ihrer herstellung, und ihre verwendung als medikament
JPH0483431A (ja) * 1990-07-26 1992-03-17 Seiko Epson Corp 選択呼出受信機
SE9203318D0 (sv) * 1992-11-06 1992-11-06 Kabi Pharmacia Ab Novel 3,3-diphenylpropylamines, their use and preparation
SE9701144D0 (sv) * 1997-03-27 1997-03-27 Pharmacia & Upjohn Ab Novel compounds, their use and preparation
EP0957073A1 (en) * 1998-05-12 1999-11-17 Schwarz Pharma Ag Novel derivatives of 3,3-diphenylpropylamines
DE19955190A1 (de) * 1999-11-16 2001-06-21 Sanol Arznei Schwarz Gmbh Stabile Salze neuartiger Derivate von 3,3-Diphenylpropylaminen

Also Published As

Publication number Publication date
JP2007137895A (ja) 2007-06-07
EA005588B1 (ru) 2005-04-28
DK1230209T3 (da) 2005-05-30
PL356766A1 (en) 2004-07-12
EA200200511A1 (ru) 2002-10-31
JP4083431B2 (ja) 2008-04-30
HU0900587D0 (en) 2009-11-30
EP1230209A2 (de) 2002-08-14
ZA200203315B (en) 2003-09-23
JP5290351B2 (ja) 2013-09-18
NO20065380L (no) 2002-05-15
PT1481964E (pt) 2006-12-29
SK6572002A3 (en) 2002-12-03
HUP0204034A3 (en) 2004-12-28
SI1230209T1 (en) 2005-06-30
CZ302497B6 (cs) 2011-06-15
IL149567A0 (en) 2002-11-10
ES2236032T3 (es) 2005-07-16
WO2001035957A1 (de) 2001-05-25
CY1110389T1 (el) 2015-04-29
HU228197B1 (en) 2013-01-28
PT1230209E (pt) 2005-05-31
MXPA02004603A (es) 2004-09-10
JP2003514018A (ja) 2003-04-15
IS6351A (is) 2002-04-19
EP1230209B1 (de) 2005-01-12
HK1067114A1 (en) 2005-04-01
EP1690536B1 (de) 2008-05-14
ES2270240T3 (es) 2007-04-01
WO2001035957A3 (de) 2001-12-27
IS8382A (is) 2006-03-29
BRPI0015610B1 (pt) 2016-04-19
NO332637B1 (no) 2012-11-26
UA73324C2 (uk) 2005-07-15
AU2666701A (en) 2001-05-30
KR100563149B1 (ko) 2006-03-21
NZ519230A (en) 2004-11-26
DE50013365D1 (de) 2006-10-05
JP5717824B2 (ja) 2015-05-13
HUP0204034A2 (hu) 2003-03-28
JP5650924B2 (ja) 2015-01-07
CA2389749C (en) 2009-03-31
DE19955190A1 (de) 2001-06-21
GEP20084430B (OSRAM) 2008-07-25
HU227608B1 (en) 2011-09-28
ES2236032T7 (es) 2012-06-14
CZ20021343A3 (cs) 2002-09-11
EP1230209B3 (de) 2011-10-05
NO20022314L (no) 2002-05-15
CA2389749A1 (en) 2001-05-25
SI1481964T1 (sl) 2006-12-31
EP1481964B1 (de) 2006-08-23
PL201422B1 (pl) 2009-04-30
ATE395056T1 (de) 2008-05-15
KR20050100711A (ko) 2005-10-19
US6858650B1 (en) 2005-02-22
HK1095736A1 (en) 2007-05-18
IS2673B (is) 2010-09-15
DE50009239D1 (de) 2005-02-17
EP1481964A1 (de) 2004-12-01
JP2010180242A (ja) 2010-08-19
BR0015610B8 (pt) 2017-10-31
IS2124B (is) 2006-07-14
SK287430B6 (sk) 2010-09-07
NO20022314D0 (no) 2002-05-15
HK1045148B (zh) 2005-05-06
SI1690536T1 (sl) 2008-08-31
EP1690536A2 (de) 2006-08-16
HUP0900587A3 (en) 2010-04-28
KR100536095B1 (ko) 2005-12-12
HK1045148A1 (en) 2002-11-15
DK1481964T3 (da) 2006-11-27
KR20020059744A (ko) 2002-07-13
DE29923134U1 (de) 2000-06-29
DE50015163D1 (de) 2008-06-26
CN1215045C (zh) 2005-08-17
ATE286872T1 (de) 2005-01-15
CZ302967B6 (cs) 2012-01-25
JP2010180243A (ja) 2010-08-19
UA77322C2 (en) 2006-11-15
PT1690536E (pt) 2008-07-14
NO323920B1 (no) 2007-07-23
EP1690536A3 (de) 2006-08-23
ATE337293T1 (de) 2006-09-15
SK288185B6 (sk) 2014-04-02
JP2011148824A (ja) 2011-08-04
JP5503393B2 (ja) 2014-05-28
BR0015610A (pt) 2002-07-30
ES2303708T3 (es) 2008-08-16
AU778132B2 (en) 2004-11-18
CY1106204T1 (el) 2011-06-08
IL149567A (en) 2007-08-19
WO2001035957A8 (de) 2001-06-21
DK1690536T3 (da) 2008-09-01
JP2014111589A (ja) 2014-06-19
CN1390194A (zh) 2003-01-08
SK288384B6 (sk) 2016-08-01

Similar Documents

Publication Publication Date Title
BRPI0015610C1 (pt) composto derivado de 3,3-difenilpropilamina, processo para preparação do mesmo, utilização de intermediários na obtenção do referido composto
PE20231438A1 (es) Proceso para hacer un inhibidor de pd-1/pd-l1 y sales y formas cristalinas del mismo
BR0112224A (pt) Composto, composição farmacêutica, uso de um composto ou de um sal, solvato ou pró-droga farmaceuticamente aceitável do mesmo, e, processo para preparar um composto
BR0313831A (pt) Sais benzenossulfonato de derivados de 4-flúor-2-cianopirrolidina
PE20061142A1 (es) Forma cristalina gamma de clorhidrato de ivabradina, su procedimiento de preparacion y composiciones farmaceuticas que la contienen
UY30440A1 (es) Nuevos compuestos
BR0314379A (pt) Quinazolinonas espirocondensadas e a sua utilização como inibidores de fosfodiesterase
DOP2002000512A (es) Sales de acido succinato de 5,7,14-triazatetraciclo [10.3.1.0² ¹¹.04,9] hexadeca-2 (11),3,5,7,9-pentaeno y composiciones farmaceuticas de las mismas
AR044694A1 (es) Proceso y compuestos intermedios para la preparacion de (1r, 2s,5s) - 3 azabiciclo [3,1,0] hexano-2- carboxamida, n- [3- amino-1- (ciclobutilmetil) - 2, 3 - dioxopropil] -3- [ (2s) - 2 - [[ [ 1,1- dimetiletil] amino] carbonilamino] -3,3-dimetil -1- oxobutil]-6,6 dimetilo
BRPI0603043A (pt) forma cristalina iv de agomelatina, um processo para sua preparação e composições farmacêuticas contendo-a
AR082581A2 (es) Procedimientos de preparacion de combretastatinas
BRPI0804091A2 (pt) compostos de 1,2,4,5-tetrahidro-3h-benzazepina, processo para sua preparação e composições farmacêuticas que os contêm
BRPI0409105A (pt) análogos de quinobenzoxazina substituìdos
BR9708233A (pt) Processo para sìntese de um composto e composto.
BR0211691A (pt) Processo para a prepara de tolterodina
BRPI0708278B8 (pt) forma cristalina "a" do sal de arginina de perindopril, seu uso, processo para sua preparação e composição farmacêutica
CO5720995A2 (es) Compuesto novedoso
BRPI0507334A (pt) processo para a preparação de -1(2s,3s)-2-benzidril-n-(5-terc-butil-2-metoxibenzila)q uinuclidin-3-amina
AR056014A1 (es) Compuesto 3-aminocarbazol, composicion farmaceutica que lo contiene y procedimiento para la preparacion del mismo
KR101494231B1 (ko) 항바이러스 화합물
BRPI0414554A (pt) compostos e seus usos em medicina: processo para preparação destes e composições farmacêuticas que os contenham
AR037827A1 (es) Procedimiento de preparacion de derivados de equinocandina
AR044175A1 (es) Compuestos de cefemo
ECSP045192A (es) "SALES ESTABLES DEL ACIDO o-ACETILSALICILICO CON AMINOÁCIDOS BÁSICOS II"
BR0113259A (pt) Processo para a preparação de um composto, composto e processo para a preparação de compostos

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O E 13 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI.

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 19/04/2016, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 15/11/2000 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 15/11/2020